Student Resources | Faculty, Postdoc, & Staff Resources
Search for:
Give now button Admin Login

Posts classified under: P

Carlos Portera-Cailliau

Carlos Portera-Cailliau, M.D., Ph.D.

Faculty Member

Professor
Department of Neurology
Department of Neurobiology
David Geffen School of Medicine
University of California, Los Angeles

 

710 Westwood Plaza
Los Angeles, CA 90095

 

Biography

The Portera-Cailliau laboratory investigates how developmental defects in network connectivity at the level of the cerebral cortex directly lead to symptoms of autism, learning disability and intellectual dysfunction. In particular they are studying sensory hypersensitivity in a model of fragile X syndrome, by combining in vivo two-photon calcium imaging, patch-clamp electrophysiology, and head-fixed behavior.  Dr. Portera-Cailliau was born and raised in Madrid, Spain. He obtained a B.A. in Biochemistry & Cell Biology from U.C. San Diego in 1990. He then attended the Johns Hopkins School of Medicine and obtained an MD-PhD degree in 1997. His mentors were Drs. Donald Price and Lee Martin. After finishing a residency in Neurology at The Massachusetts General Hospital and Brigham & Women’s Hospital in Boston in 2001, Dr. Portera-Cailliau moved to Columbia University for a post-doctoral fellowship in Dr. Rafael Yuste’s laboratory. His second post-doc was with Dr. Karel Svoboda in Cold Spring Harbor Laboratory. He joined the UCLA faculty in November 2004 and has joint appointments in the Departments of Neurology and Neurobiology. He is a member of UCLA’s Brain Research Institute, the Integrated Center for Learning & Memory, and the Neuroscience Theme.  Since 2013 he has served as co-director of the UCLA-Caltech Medical Scientist Training Program.

Robert M. Prins, Ph.D.

Robert Prins, Ph.D.

Faculty Member

Associate Professor
Department of Neurosurgery
Department of Molecular & Medical Pharmacology
David Geffen School of Medicine
University of California, Los Angeles

 

Robert M. Prins Lab
UCLA Department of Neurosurgery
Edie & Lew Wasserman Building
300 Stein Plaza, Suite 420
Los Angeles, CA 90095

 

Biography

Robert M. Prins is a tumor immunologist with joint faculty appointments in the Departments of Neurosurgery and Molecular and Medical Pharmacology. Dr. Prins earned his B.S. in Kinesiology and his M.S. in Physiological Science from the University of California, Los Angeles. He earned his Ph.D. in Anatomy and Immunology from the Medical College of Virginia. He completed post-doctoral fellowships at the Cedars-Sinai Neurosurgical Institute and the UCLA Division of Neurosurgery before joining the faculty at UCLA in 2006. Dr. Prins is a member of the Jonsson Comprehensive Cancer Center, the Brain Research Institute, and the Parker Institute for Cancer Immunotherapy. Dr. Prins is currently the Director of the I3T Seminar Series, the Brain Tumor Immunology Research Lab and for many clinical trials of immunotherapy. His research centers on understanding the immunology of malignant brain tumors and devising new immune-based therapies to treat these deadly tumors.

Yi-Rong Peng, Ph.D.

Yi-Rong Peng, Ph.D.

Faculty

Assistant Professor
Department of Ophthalmology
Jules Stein Eye Institute
David Geffen School of Medicine
University of California, Los Angeles

 

UCLA Jules Stein Institute
100 Stein Plaza, Room B-222B
Los Angeles, CA 90095

 

Biography

Dr. Peng received her PhD in neurobiology from the Institute of Neuroscience, Chinese Academy of Sciences, Shanghai, China in 2011. Her doctoral research examined the role of functional interactions between inhibitory and excitatory synapses that maintain the stability of neural networks. She then joined the laboratory of Dr. Joshua Sanes at Harvard University, where she was a postdoctoral fellow until 2019. In her postdoctoral work, she leveraged high throughput single-cell transcriptomic methods to uncover key transcriptional factors that control the specification of retinal cell types.

At the Stein Eye Institute she will continue to develop state-of-the-art transcriptomic and genomic tools to uncover the molecular underpinnings of the formation of retinal circuits and the pathogenesis of retinal diseases.

1 2 3 4